Centric Wealth Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,000
Closed -$100K 196
2025
Q3
$100K Hold
40,000
0.02% 185
2025
Q2
$128K Buy
+40,000
New +$145K 0.03% 187
2024
Q4
Sell
-74,141
Closed -$453K 167
2024
Q3
$453K Hold
74,141
0.12% 121
2024
Q2
$477K Buy
74,141
+53,188
+254% +$423K 0.14% 104
2024
Q1
$172K Sell
20,953
-10,002
-32% -$81.6K 0.05% 156
2023
Q4
$220K Sell
30,955
-130,005
-81% -$992K 0.07% 149
2023
Q3
$1.32M Buy
+160,960
New +$1.56M 0.55% 54

Other funds holding BAK

Centric Wealth Management's BAK Position: Q4 2025 in Review

Centric Wealth Management sold out of Braskem (BAK) in Q4 2025, closing a stake of 40,000 shares — an estimated $100K sold.

Centric Wealth Management first reported a position in BAK in Q3 2023 and held it in 7 quarters. The position peaked at $1.32M in Q3 2023. 53 funds tracked by Wall St. Rank hold BAK as of Q4 2025.

  • Centric Wealth Management reported no remaining Braskem position as of Q4 2025 after selling out during the quarter.
  • Centric Wealth Management sold 40,000 Braskem shares in Q4 2025, an estimated $100K.
  • Centric Wealth Management first reported a position in Braskem in Q3 2023 and held it in 7 quarters.
  • Centric Wealth Management's Braskem position peaked at $1.32M in Q3 2023.
  • 53 funds tracked by Wall St. Rank held Braskem as of Q4 2025.

Based on Centric Wealth Management's 13F filing for Q4 2025, filed 4 Feb 2026.